Lapix Therapeutics Inc.
Clinical trials sponsored by Lapix Therapeutics Inc., explained in plain language.
-
New pill tested for common arthritis types
Disease control Recruiting nowThis early-stage study is testing the safety and tolerability of a new oral drug called LPX-TI641 in people with rheumatoid arthritis or psoriatic arthritis. About 48 participants will take the drug or a placebo pill daily for 28 days. The main goal is to see how well the drug is…
Phase: PHASE1 • Sponsor: LAPIX Therapeutics Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New pill tested for tough skin conditions
Disease control Recruiting nowThis is an early-stage study to check the safety and how the body processes a new oral drug called LPX-TI641. It will involve about 48 adults with moderate-to-severe eczema (atopic dermatitis) or plaque psoriasis. Participants will take the drug or a placebo pill daily for 28 day…
Phase: PHASE1 • Sponsor: LAPIX Therapeutics Inc. • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC